First- vs second-line CDK 4/6 inhibitor use for patients with hormone receptor positive, human epidermal growth-factor receptor-2 negative, metastatic breast cancer in the real world setting [PDF]
Gretchen Kimmick +4 more
openalex +1 more source
Exploiting targeted degradation of cyclins and cyclin-dependent kinases for cancer therapeutics: a review. [PDF]
Zheng S +8 more
europepmc +1 more source
Origin recognition complex subunit 1 functions as an oncogenic driver and therapeutic target in cancer. [PDF]
Ding Y, Cai S, Cai J, Wang Z, Zhu Z.
europepmc +1 more source
An Orc6 tether mediates ORC binding-site switching during replication origin licensing. [PDF]
Driscoll D +3 more
europepmc +1 more source
Editorial commentary on the special issue of cancer research. [PDF]
Editorial Board.
europepmc +1 more source
Regulation of cell proliferation by a novel feedback system on Cdk function
Ryan JC +24 more
europepmc +1 more source
Cdk activation by phosphorylation: linking growth signals to cell cycle control. [PDF]
Blank HM, No EG, Polymenis M.
europepmc +1 more source
Iron Supplementation with Ferrous Sulfate or Ferrous Bisglycinate for 12 Weeks Does Not Influence Group B Streptococcus Colonization in Cambodian Women: A Secondary Analysis of a Randomized Controlled Trial. [PDF]
Cirigliano E +7 more
europepmc +1 more source
An NMR Database for Organic and Organometallic Compounds. [PDF]
Kuhn S, Fischer M, Rull H, Farès C.
europepmc +1 more source

